Search

Your search keyword '"Thonberg, H"' showing total 88 results

Search Constraints

Start Over You searched for: Author "Thonberg, H" Remove constraint Author: "Thonberg, H"
88 results on '"Thonberg, H"'

Search Results

1. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)

2. Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

3. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

4. New insights into the genetic etiology of Alzheimer's disease and related dementias

5. Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia

7. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

8. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

10. Disease-related cortical thinning in presymptomatic granulin mutation carriers

11. Abnormal pain perception is associated with thalamo-cortico-striatal atrophy in C9orf72 expansion carriers in the GENFI cohort

12. Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia

13. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

14. Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

15. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

16. Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

17. Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study

18. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study

19. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A beta, tau, immunity and lipid processing (vol 51, pg 414, 2019)

20. Nat Genet

21. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

22. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing

23. Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort

24. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

25. Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI)

26. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

27. Meta-analysis of genetic association with diagnosed Alzheimer's disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing

28. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

29. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

30. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study

31. Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease

32. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

33. Clinical characterisation of SORL1 mutation carriers in a European early-onset Alzheimer's disease cohort

34. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis

35. TBK1 loss-of function and dominant-negative mutations in an extended European cohort of FTD and ALS patients

37. Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing

39. TBK1 loss-of function and dominant-negative mutations in an extended European cohort of FTD and ALS patients

40. Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon.

41. Reduced cone photoreceptor function and subtle systemic manifestations in two siblings with loss of SCLT1.

42. Transposable element insertions in 1000 Swedish individuals.

43. Genome sequencing with comprehensive variant calling identifies structural variants and repeat expansions in a large fraction of individuals with ataxia and/or neuromuscular disorders.

46. Massive parallel sequencing in individuals with multiple primary tumours reveals the benefit of re-analysis.

47. Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients.

48. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.

49. Confirmation of high frequency of C9orf72 mutations in patients with frontotemporal dementia from Sweden.

50. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.

Catalog

Books, media, physical & digital resources